Publications by authors named "Matthew L Caylor"

Claim this Profile
U
Use of a Bioinformatics-Based Toxicity Scoring System to Assess Serotonin Burden and Predict Population-Level Adverse Drug Events from Concomitant Serotonergic Drug Therapy.
Vaughn L Culbertson, Shaikh Emdadur Rahman, Grayson C Bosen, Matthew L Caylor, Dong Xu

Pharmacotherapy· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ezCADD: A Rapid 2D/3D Visualization-Enabled Web Modeling Environment for Democratizing Computer-Aided Drug Design.
Aoxiang Tao, Yuying Huang, Yasuhiro Shinohara, Matthew L Caylor, Srinath Pashikanti

J Chem Inf Model· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of Off-Target Serotoninergic Drug Activity: An Analysis of Serotonin Syndrome Reports Using a Systematic Bioinformatics Approach.
Vaughn L Culbertson, Shaikh E Rahman, Grayson C Bosen, Matthew L Caylor, Megan M Echevarria

Pharmacotherapy· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular insights into the improved clinical performance of PEGylated interferon therapeutics: a molecular dynamics perspective.
Dong Xu, Nikolai Smolin, Rance K Shaw, Samuel R Battey, Aoxiang Tao, Matthew L Caylor

RSC Adv· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.
Dong Xu, Alexandrea G Ham, Rickey D Tivis, Matthew L Caylor, Aoxiang Tao

EBioMedicine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis